Shockwave Therapy for Osteoarthritis of the Knee in Campbell CA

Shockwave Therapy for Osteoarthritis of the Knee in Campbell CA

Shockwave Therapy for Osteoarthritis of the Knee in Campbell CA
Download The Full Version of this Article

Knee pain affects millions of people around the world. Surgery and repeated injections are not the only ways to treat it. Extracorporeal shockwave therapy (ESWT) is a non-surgical treatment that uses sound waves to help damaged tissue heal in Campbell CA.

This article explains what ESWT is, the knee problems it can help, the research supporting it, what to expect during treatment, common questions, and who may benefit most.

In 2019, about 528 million people were living with osteoarthritis, which is more than double the number in 1990. The knee is the most common joint affected, with about 365 million cases, followed by the hip and hand. About 73% of patients are over 55 years old, and 60% are women. Around 344 million people have moderate to severe disease that requires rehabilitation. With aging populations, rising obesity, and sports injuries, the number of people with knee osteoarthritis is expected to keep increasing. This makes it one of the leading causes of disability worldwide.

Knee Conditions Shockwave Therapy Can Treat in Campbell CA

Osteoarthritis
Shockwave therapy is well studied for knee osteoarthritis. Research shows it can reduce pain, improve movement, and make daily life easier for people with mild to moderate disease. Reviews report even better outcomes when therapy is combined with exercise programs. However, the results are less consistent for advanced arthritis where the joint is severely damaged (World Health Organization; Zhao et al.; Zhong et al.).

Patellar Tendinopathy (Jumper’s Knee)
Patellar tendinopathy is common in athletes and active adults. Shockwave therapy can help tendons heal, ease pain, and restore function. Both radial and focused shockwave devices have been used successfully, although results can vary depending on training demands and timing. Some trials found added benefit when therapy was combined with eccentric exercise, while others showed mixed results (Wang et al.; Zwerver et al.; Persson Krogh et al.; van der Worp et al.).

Bursitis and Overuse Inflammation
Knee bursitis and irritation of the IT band also respond well to shockwave therapy. Research suggests the benefits last longer than those from steroid injections, without the risks linked to repeated medications (Gouda et al.).

Post-Surgical and Chronic Knee Pain
Shockwave therapy is sometimes used after surgery to reduce scar tissue, improve blood flow, and manage ongoing pain. Studies consistently show it to be safe, with very few complications reported.

Benefits vs Standard Care

Unlike treatments that mainly mask symptoms, ESWT helps promote real healing. Compared with corticosteroid injections, ESWT often provides longer-lasting pain relief and better function, without the risks of steroids such as tissue thinning or body-wide side effects (Gouda et al.). When compared with anti-inflammatory drugs or single injections, ESWT helps trigger repair and may reduce the need for medication. Results compared with hyaluronic acid or platelet-rich plasma (PRP) vary depending on the condition and study, though some trials show similar benefits in the medium term.

For osteoarthritis, reviews of multiple studies show meaningful improvements in pain and function scores, especially when medium energy levels are used. Downsides include uneven insurance coverage and less predictable results in severe “bone-on-bone” arthritis. ESWT is not a cure for advanced joint collapse, but it is a safe option to try before moving on to surgery.

What to Expect

A typical session lasts 15 to 20 minutes. Most programs use 5 to 10 sessions spread over 3 to 8 weeks. During treatment, patients feel tapping or pulsing sensations. No anesthesia is usually needed, and patients can walk out and return to most activities right away. Some may feel mild soreness or notice temporary redness at the site. Medium energy settings often produce stronger results, though they may also feel slightly more uncomfortable during treatment.

Why Patients Are Choosing Shockwave Therapy

Many patients are looking for options beyond surgery and drugs. Shockwave therapy is attractive because it helps tissues heal instead of just covering up symptoms. It does not require anesthesia, has little to no downtime, and lets patients resume normal activities immediately. Unlike repeated injections, which can have risks over time, ESWT stimulates the body’s own repair systems. This mix of safety, convenience, and proven benefits is why more patients and doctors are turning to shockwave therapy as a middle option between basic care and surgery.

Shockwave Therapy Compared with Injections and Surgery

Steroid or hyaluronic acid injections can provide short-term relief but do not change the disease process, and repeated use may cause side effects. Surgery remains the best choice for advanced joint collapse, but it carries higher risks and longer recovery times. Shockwave therapy offers improvements in pain and function for early to moderate disease, with fewer complications and lower long-term costs. Clinical trials show lasting benefits in both osteoarthritis and tendon problems, making ESWT a strong option before more invasive steps.

Frequently Asked Questions

Is shockwave therapy effective for knee osteoarthritis?
Yes. Research shows it reduces pain and stiffness while improving function, especially in mild to moderate cases. Many patients notice results within three months, and benefits can last longer.

How many sessions are needed?
Most treatment plans include 4 to 10 sessions over 3 to 8 weeks. The number of pulses and energy levels can also affect results.

Can shockwave therapy help with “bone-on-bone” arthritis?
Results are less predictable in severe osteoarthritis with major joint damage. It works best in earlier stages.

Is shockwave therapy better than injections or surgery?
For bursitis and tendon problems, research suggests shockwave therapy can provide longer relief than steroid injections without the risks. It is not a replacement for knee replacement surgery but can be an important option before considering surgery.

Does shockwave therapy work for athletes with tendon problems?
Yes. It is especially helpful for jumper’s knee (patellar tendinopathy). Results tend to be better during the off-season, and combining therapy with exercise may improve outcomes, though results vary.

Are there any risks or side effects?
Side effects are usually mild and temporary, such as soreness, bruising, or numbness in the treated area. Serious problems are very rare.

Will insurance cover it?
Coverage depends on the provider, however insurance coverage is very rare.  Many clinics providing this service also offer self-pay options.

Who Should Consider It?

Shockwave therapy is a good option for people with chronic knee pain from mild to moderate osteoarthritis, chronic patellar tendinopathy, or ongoing bursitis, especially if exercise, bracing, or medication have not worked. It is also useful for those wanting to avoid surgery or repeated injections. It is not recommended for pregnant patients, people with bleeding disorders that are not controlled, or those with cancer at the treatment site.

Conclusion

Extracorporeal shockwave therapy is a safe, research-supported, non-surgical treatment for certain knee problems. Studies show it can reduce pain and improve function in the short and medium term, especially in patients with mild to moderate osteoarthritis and tendon problems. Results depend on factors like energy level, number of sessions, and timing with activity levels.

If you are living with persistent knee pain despite standard care, consider asking a specialist about ESWT. A professional can review your medical history and imaging to determine if you are a candidate.

Call Spine & Injury Center at (408) 379-8888 or visit our website to schedule your assessment.

Low-level laser therapy (LLLT) and photobiomodulation are FDA-cleared for circulation and pain, not specifically neuropathy reversal. RCTs show benefits in pain, sensation and nerve conduction and clinicians may use them “off-label” when evidence supports it.

Conclusion

Neuropathy management has advanced beyond symptomatic drug therapy with growing evidence for noninvasive interventions that target underlying mechanisms of nerve damage. Photobiomodulation, extracorporeal shockwave therapy, electrical stimulation, vibration-based sensory retraining, and carefully selected nutritional supplements demonstrate measurable improvements in pain, sensation and nerve conduction, especially in diabetic and chemotherapy-induced neuropathy. Chiropractic care and physical rehabilitation like vertebral axial decompression (when needed) further enhance circulation, improve sensorimotor function, and optimize body mechanics to support nerve health and functional capacity. Early treatment remains critical, as progressive axonal degeneration limits recovery potential. Patients benefit most when therapies are tailored to individual needs, monitored by clinicians and integrated with metabolic control and lifestyle interventions. This evidence-based, nonpharmacological approach emphasizes neuroprotection, regeneration and functional restoration, offering a realistic path toward improved quality of life and, in many cases, partial nerve recovery.

References

  1. Abdullah, N., Tieppo Francio, V., Falowski, S., Ibrahim, Y., Malinowski, M., Budwany, R., ... & Pritzlaff, S. (2024). A Systematic Guideline by the ASPN Workgroup on the Evidence, Education and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET.
  2. Advantage Health Center. (2025, April 7). Case study: Relief from peripheral neuropathy with chiropractic care. Advantage Health. https://advantage-healthcenter.com/case-study-neuropathy-relief-eau-claire
  3. Argenta, P. A., Ballman, K. V., Geller, M. A., Carson, L. F., Ghebre, R., Mullany, S. A., Teoh, D. G., Winterhoff, B. J., Rivard, C. L., & Erickson, B. K. (2016). The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial. Gynecologic Oncology, 144(1), 159–166. https://doi.org/10.1016/j.ygyno.2016.11.013
  4. Baskozos, G., et al. (2023). Epidemiology of neuropathic pain: An analysis of prevalence. Pain Reports, 8(4), e1056. [Note: complete author list not specified; include as appropriate in final bibliography.
  5. Beltramo, E., Berrone, E., Tarallo, S., & Porta, M. (2008). Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta diabetologica, 45(3), 131-141.
  6. Blum, K., Chen, A. L., Chen, T. J., Prihoda, T. J., Schoolfield, J., DiNubile, N., Waite, R. L., Arcuri, V., Kerner, M., Braverman, E. R., Rhoades, P., & Tung, H. (2008). The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Advances in Therapy, 25(7), 644–657. https://doi.org/10.1007/s12325-008-0073-3
  7. Chen, Y., Chen, K., Yin, T., Huang, T., Yuen, C., Chung, S., Sung, P., Tong, M., Chen, C., Chang, H., Lin, K., Ko, S., & Yip, H. (2015, December 15). Extracorporeal shock wave therapy effectively prevented diabetic neuropathy. https://pmc.ncbi.nlm.nih.gov/articles/PMC4731656
  8. Chiropractic, A. (2025, April 7). Case study: Treating peripheral neuropathy with Chiropractic care. Advantage Chiropractic. https://www.chiropractornewberlin.com/case-study-treating-neuropathy-with-chiropractic
  9. Comparative efficacy of chiropractic adjustments in peripheral neuropathy management. (n.d.). https://www.backinactionbodyworks.com/blog/comparative-efficacy-of-chiropractic-adjustments-in-peripheral-neuropathy-management
  10. De La Corte-Rodríguez, H., Román-Belmonte, J. M., Rodríguez-Damiani, B. A., Vázquez-Sasot, A., & Rodríguez-Merchán, E. C. (2023). Extracorporeal shock wave therapy for the treatment of musculoskeletal pain: A Narrative review. Healthcare, 11(21), 2830. https://doi.org/10.3390/healthcare11212830
  11. De Oliveira Marques, C., Espindula, I. A., Darko, E. K. K., Bonetti, L. V., Sonza, A., Partata, W. A., Faccioni-Heuser, M. C., & Malysz, T. (2021). Whole-body vibration therapy does not improve the peripheral nerve regeneration in experimental model. https://pmc.ncbi.nlm.nih.gov/articles/PMC8020024
  12. De Oliveira Rosso, M. P., Buchaim, D. V., Kawano, N., Furlanette, G., Pomini, K. T., & Buchaim, R. L. (2018). Photobiomodulation therapy (PBMT) in Peripheral Nerve Regeneration: A Systematic review. Bioengineering, 5(2), 44. https://doi.org/10.3390/bioengineering5020044
  13. Dompe, C., Moncrieff, L., Matys, J., Grzech-Leśniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., Skiba, T., Shibli, J., Volponi, A. A., Kempisty, B., & Dyszkiewicz-Konwińska, M. (2020). Photobiomodulation—Underlying mechanism and clinical applications. Journal of Clinical Medicine, 9(6), 1724. https://doi.org/10.3390/jcm9061724
  14. Ebadi, S. A., Tabeie, F., Tavakoli, S., & Khalili, S. (2023). Effects of Photobiomodulation With Two Wavelengths of 630 and 810 nm on Diabetic Neuropathy. Journal of Lasers in Medical Sciences, 14, e22. https://doi.org/10.34172/jlms.2023.22
  15. Effect of extracorporeal shockwaves on diabetic neuropathic foot. (2020). International Journal of Pharmaceutical Research, 12(04). https://doi.org/10.31838/ijpr/2020.sp2.554
  16. Elafros, M. A., Kvalsund, M. P., & Callaghan, B. C. (2022). The global burden of polyneuropathy—In need of an accurate assessment. JAMA Neurology, 79(6), 537–538. https://doi.org/10.1001/jamaneurol.2022.0565
  17. Foundation for Peripheral Neuropathy. (2025). The global burden of polyneuropathy. Retrieved from Foundation for Peripheral Neuropathy website.
  18. Fraser, D. A., Diep, L. M., Hovden, I. A., Nilsen, K. B., Sveen, K. A., Seljeflot, I., & Hanssen, K. F. (2012). The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care, 35(5), 1095-1097.
  19. Ghoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Jafarabadi, M. A., Montazeri, V., Keshavarz, S. A., & Darabi, M. (2012). Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial. BMC Cancer, 12(1). https://doi.org/10.1186/1471-2407-12-355
  20. Guo, J., Hai, H., & Ma, Y. (2022). Application of extracorporeal shock wave therapy in nervous system diseases: A review. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.963849
  21. Hammi C, Yeung B. Neuropathy [Internet]. StatPearls - NCBI Bookshelf. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542220/
  22. Health Sciences Authority. (2023). High-dose vitamin B6 and risk of peripheral neuropathy. Retrieved from https://www.hsa.gov.sg/announcements/safety-alert/high-dose-vitamin-b6-and-risk-of-peripheral-neuropathy
  23. Hicks, C. W., Wang, D., Windham, B. G., Matsushita, K., & Selvin, E. (2021). Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Scientific Reports, 11(1), Article 19159. https://doi.org/10.1038/s41598-021-98565-w
  24. International Society for Medical Shockwave Treatment. (2024, January 3). ISMST guidelines for extracorporeal shock wave therapy (ESWT). https://shockwavetherapy.org/wp-content/uploads/2024/01/ISMST-Guidelines-for-ESWT-_-engl-20240103.pdf
  25. Jamal, A., Ahmad, I., Ahamed, N., Azharuddin, M., Alam, F., & Hussain, M. E. (2019). Whole body vibration showed beneficial effect on pain, balance measures and quality of life in painful diabetic peripheral neuropathy: a randomized controlled trial. Journal of Diabetes & Metabolic Disorders, 19(1), 61–69. https://doi.org/10.1007/s40200-019-00476-1
  26. Jeong, D., Lee, J. H., Lee, G. B., Shin, K. H., Hwang, J., Jang, S. Y., Yoo, J., & Jang, W. Y. (2023). Application of extracorporeal shockwave therapy to improve microcirculation in diabetic foot ulcers: A prospective study. Medicine, 102(11), e33310. https://doi.org/10.1097/md.0000000000033310
  27. Johnson, M. I., et al. (2022). A secondary analysis of the Meta-TENS study to improve pain management. Nih. 58(6), 803. https://doi.org/10.3390/jcm58060803
  28. Johnson, M. I., Paley, C. A., Jones, G., Mulvey, M. R., & Wittkopf, P. G. (2022). Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study). BMJ Open, 12(2), e051073. https://doi.org/10.1136/bmjopen-2021-051073
  29. Johnson, M. I., Paley, C. A., Wittkopf, P. G., Mulvey, M. R., & Jones, G. (2022). Characterising the features of 381 clinical studies evaluating transcutaneous electrical nerve stimulation (TENS) for pain relief: A secondary analysis of the Meta-TENS Study to improve future research. Medicina, 58(6), 803. https://doi.org/10.3390/medicina58060803
  30. Joshua, A. M., & Misri, Z. (2022). Peripheral nerve disorders. In Physiotherapy for Adult Neurological Conditions (pp. 621-729). Singapore: Springer Nature Singapore.
  31. Kessler, N. J., Lockard, M. M., & Fischer, J. (2020). Whole body vibration improves symptoms of diabetic peripheral neuropathy. Journal of Bodywork and Movement Therapies, 24(2), 1–3. https://doi.org/10.1016/j.jbmt.2020.01.004
  32. Korada, H. Y., Arora, E., Maiya, G. A., Rao, S., Hande, M., Shetty, S., Gundmi, S., Anche, P., & Amravadi, S. (2022). Effectiveness of photobiomodulation therapy on neuropathic pain, nerve conduction and plantar pressure distribution in diabetic peripheral neuropathy - a systematic review. Current Diabetes Reviews, 19(9). https://doi.org/10.2174/1573399818666220429085256
  33. Kou, D., Chen, Q., Wang, Y., Xu, G., Lei, M., Tang, X., Ni, H., & Zhang, F. (2024). The application of extracorporeal shock wave therapy on stem cells therapy to treat various diseases. Stem Cell Research & Therapy, 15(1). https://doi.org/10.1186/s13287-024-03888-w
  34. Krasnow, S. M., Rubin, C. T., Roeland, E. J., Horak, F. B., Stoyles, S. A., Dieckmann, N. F., Braun, K. N., & Winters-Stone, K. M. (2025). Low-Intensity vibration to reduce symptoms and improve physical functioning in cancer survivors with Chemotherapy-Induced peripheral neuropathy: a pilot randomized trial. JCO Oncology Practice. https://doi.org/10.1200/op-24-00961
  35. Laforgia, M., Laface, C., Calabro, C., Ferraiuolo, S., Ungaro, V., Tricarico, D., ... & Ranieri, G. (2021). Peripheral neuropathy under oncologic therapies: a literature review on pathogenetic mechanisms. International journal of molecular sciences, 22(4), 1980.
  36. Li L, Li T, Qu X, Sun G, Fu Q, Han G. Stress/cell death pathways, neuroinflammation and neuropathic pain. Immunological reviews. 2024 Jan;321(1):33-51.
  37. Liu, Y. W., Liu, C. T., & Su, Y. L. (2020). A narrative review of complementary nutritional supplements for chemotherapy-induced peripheral neuropathy. Alternative Therapies in Health and Medicine, 26(4), 43-49.
  38. Robinson, C. C., Barreto, R. P. G., & Della Méa Plentz, R. (2018, September 1). Effects of whole body vibration in individuals with diabetic peripheral neuropathy: a systematic review. https://pmc.ncbi.nlm.nih.gov/articles/PMC6146195
  39. Rotaru, A., TÂrtea, E. A., & IancĂu, M. (2020). Classical therapies versus combined therapies in diabetic neuropathy. PubMed, 46(2), 123–128. https://doi.org/10.12865/chsj.46.02.04
  40. Sabziparvar, M., Naghdi, S., Ansari, N. N., & Fateh, H. (2022). Implication of Local Plantar Vibration in Patients with Diabetic Neuropathy. Iranian Journal of Public Health. https://doi.org/10.18502/ijph.v51i8.10284
  41. Saleh DO, Sedik AA. Novel drugs affecting diabetic peripheral neuropathy. Iranian Journal of Basic Medical Sciences. 2024;27(6):657.
  42. Sohrabzadeh, E., Kalantari, K. K., Naimi, S. S., Daryabor, A., & Akbari, N. J. (2021). The immediate effect of a single whole-body vibration session on balance, skin sensation and pain in patients with type 2 diabetic neuropathy. Journal of Diabetes & Metabolic Disorders, 21(1), 43–49. https://doi.org/10.1007/s40200-021-00933-w
  43. Tassone, E. E., Page, J. C., & Slepian, M. J. (2023). Assessing the effects of pulsed electromagnetic therapy on painful diabetic distal symmetric peripheral neuropathy: a Double-Blind randomized controlled trial. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968231190413
  44. Therapeutic Goods Administration. (2022). Health supplements containing vitamin B6 can cause peripheral neuropathy. Retrieved from https://www.tga.gov.au/news/safety-alerts/health-supplements-containing-vitamin-b6-can-cause-peripheral-neuropathy
  45. Vance, C. G. T., Dailey, D. L., Chimenti, R. L., Van Gorp, B. J., Crofford, L. J., & Sluka, K. A. (2022). Using TENS for pain control: Update on the state of the evidence. Medicina, 58(10), 1332. https://doi.org/10.3390/medicina58101332
  46. Vorobeychik, Y., Gordin, V., Mao, J., & Chen, L. (2011). Combination therapy for neuropathic pain. CNS Drugs, 25(12), 1023–1034. https://doi.org/10.2165/11596280-000000000-00000
  47. Wang, Q., et al. (2024). The effects of pulsed electromagnetic field therapy on knee osteoarthritis: A randomized controlled trial. Frontiers in Medicine, 11, 1435277. https://doi.org/10.3389/fmed.2024.1435277
  48. Williamson, T. K., Rodriguez, H. C., Gonzaba, A., Poddar, N., Norwood, S. M., & Gupta, A. (2021). H-Wave® Device stimulation: A critical review. Journal of Personalized Medicine, 11(11), 1134. https://doi.org/10.3390/jpm11111134
  49. Wolfe, D., Rosenstein, B., & Fortin, M. (2024). The effect of EMS, IFC and TENS on patient-reported outcome measures for chronic low back pain: a systematic review and meta-analysis. Frontiers in Pain Research, 5. https://doi.org/10.3389/fpain.2024.1346694
  50. Yang, L., Li, X., Li, S., Yang, J., & Meng, D. (2024). Effect of extracorporeal shock wave therapy on nerve conduction: a systematic review and meta-analysis. Frontiers in Neurology, 15. https://doi.org/10.3389/fneur.2024.1493692
  51. Zhang, A. C., De Silva, M. E. H., MacIsaac, R. J., Roberts, L., Kamel, J., Craig, J. P., Busija, L., & Downie, L. E. (2019). Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis. Nutrition Reviews, 78(4), 323–341. https://doi.org/10.1093/nutrit/nuz054
  52. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes care. 2006 Nov 1;29(11):2365-70.
  53. Ziegler, D. (2023). Pathogenetic treatments for diabetic peripheral neuropathy. Diabetes Research and Clinical Practice, 206, 110764.
  54. Ramos, G., & Martin, W. (1994). Effects of vertebral axial decompression on intradiscal pressure. Journal of Neurosurgery, 81(3), 350–353.
  55. Gose, E. E. et al. (1998). Vertebral axial decompression treatment for pain associated with herniated or degenerated discs or facet syndrome: An outcome study. Neurological Research, 20(4).
  56. Sherry E, Kitchener P, Smart R. A prospective randomized controlled study of VAX-D and TENS for the treatment of chronic low back pain. Neurol Res. 2001 Oct;23(7):780-4. doi: 10.1179/016164101101199180. PMID: 11680522.
  57. Naguszewski, W. K. et al. (2001). Dermatomal somatosensory evoked potential demonstration of nerve root decompression after VAX-D therapy. Neurological Research, 23(7).
  58. McMillin, D. S., & Sherry, E. (2002). Sudden progression of lumbar disk protrusion during vertebral axial decompression traction therapy. Mayo Clinic Proceedings.
  59. Aetna. (2025). Vertebral Axial Decompression [Clinical Policy Bulletin].

OFFICE HOURS

Monday
9:00am - 12:00pm
2:30pm - 6:00pm

Tuesday
Closed

Wednesday
9:00am - 12:00pm
2:30pm - 6:00pm

Thursday
2:00pm - 6:00pm

Friday
9:00am - 12:00pm
2:30pm - 6:00pm

Saturday & Sunday
Closed

Spine & Injury Center

420 Marathon Dr
Campbell, CA 95008

(408) 379-8888